Treatment of cancer with allogeneic natural killer (NK) cell therapies has seen rapid
development, especially use against hematologic malignancies. Clinical trials of NK cell …

Natural killer (NK) cells are lymphocytes with a key role in the defense against viral
infections and tumor cells. Although NK cells are classified as innate lymphoid cells (ILCs) …

Improving the efficacy of melanoma treatment remains an important global challenge. Here,
we combined chemotherapy with protein tyrosine phosphatase nonreceptor type 2 (Ptpn2) …

Reciprocal signaling between immune cells and ovarian cancer cells in the tumor
microenvironment can alter immune responses and regulate disease progression. These …

Ovarian cancer, one of the deadliest malignancies, lacks effective treatment, despite
advancements in surgical techniques and chemotherapy. Thus, new therapeutic …

Chimeric antigen receptor (CAR) T cells have been successfully used in adoptive cell
therapy for malignancies. However, some obstacles, including side effects such as graft …

Abstract Triple-Negative Breast Cancer (TNBC), the most common invasive breast cancer,
depicts cancer poor response to conventional therapies. The clinical management of TNBC …

Natural killer (NK)‐cell immunotherapy as an alternative to T‐cell immunotherapy has been
widely used in clinical cell immunotherapy of various tumors. Despite the surprising findings …

Purpose: Targeted therapeutics are a goal of medicine. Methods for targeting T-cell
lymphoma lack specificity for the malignant cell, leading to elimination of healthy cells. The T …

Patients with cancer require efficient treatment approaches as the mortality rate due to their
disease is high. Conventional therapies, like chemotherapy and radiation, have severe side …